Crist Frangakis is a founder and the CEO of Achelios Therapeutics. He has over 25 years of experience in pharmaceutical research and development, licensing, and business development. He led the discovery and development of several cardiovascular and metabolic drugs, serving as scientist and section head of research at Burroughs Welcome and Glaxo. In addition, Crist had responsibility for pharmaceutical licensing and corporate development for 13 years at Johnson & Johnson and Bayer and closed on several successful major partnering deals. He received his Ph.D. in pharmacology from the University of Arizona and a B.S. in chemistry from South Carolina. Crist is an author of over 70 publications published in peer-refereed journals and 15 issued and pending patents.
Crist J. Frangakis
